Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pacgen Life Science Corp.
DescriptionSelective antagonist of interleukin-8 (IL-8) binding to CXCR1 and CXCR2 receptor
Molecular Target CXC chemokine receptor 1 (CXCR1) ; CXC chemokine receptor 2 (CXCR2) (IL8RB)
Mechanism of ActionInterleukin-8 (IL-8) (CXCL8) inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory distress syndrome (RDS)
Indication DetailsTreat acute respiratory distress syndrome (ARDS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today